Encompass Health Corporation Debt Conversion, Converted Instrument, Amount
Encompass Health Corporation (EHC) reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2020-02-27
- Encompass Health Corporation debt conversion, converted instrument, amount for the quarter ending 2018-12-31 was $0.00.
- Encompass Health Corporation debt conversion, converted instrument, amount for the quarter ending 2018-09-30 was $0.00.
- Encompass Health Corporation debt conversion, converted instrument, amount for the quarter ending 2017-12-31 was $0.00.
- Encompass Health Corporation debt conversion, converted instrument, amount for the quarter ending 2017-09-30 was $0.00.
- Encompass Health Corporation debt conversion, converted instrument, amount for fiscal 2019 was $0.00.
- Encompass Health Corporation debt conversion, converted instrument, amount for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Encompass Health Corporation debt conversion, converted instrument, amount for fiscal 2017 was $319.40M.
- Encompass Health Corporation debt conversion, converted instrument, amount for fiscal 2016 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 1 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $0.00 10-Q · filed 2018-10-31 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $319.40M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $319.40M 10-Q · filed 2018-10-31 | |||
| 2017-06-30 | $319.40M 10-Q · filed 2018-08-02 | ||||
| 2017-05-31 | $319.40M 10-Q · filed 2017-10-31 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $0.00 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $0.00 10-Q · filed 2017-10-31 | |||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-02 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |